G01N 2440/18
Citrullination
Official title: citrullination
G01N2440/18 (Citrullination) appears on 24 US grants and 51 published applications in this corpus.
Search patents in G01N- Granted patents
- 24
- Published applications
- 51
- Assignees
- 36
- Inventors
- 103
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 0 | 4 |
| 2016 | 2 | 3 |
| 2017 | 2 | 5 |
| 2018 | 4 | 4 |
| 2019 | 4 | 2 |
| 2020 | 2 | 4 |
| 2021 | 1 | 5 |
| 2022 | 0 | 3 |
| 2023 | 1 | 6 |
| 2024 | 4 | 2 |
| 2025 | 3 | 6 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Device for inline monitoring of free nucleosomes in blood26 May 2026US 12,636,417 B2Belgian Volition SRL
- Systems and methods for rheumatoid arthritis biomarker detection13 May 2025US 12,298,302 B2Covydx, Inc.
- Anti-tumour response to modified self-epitopes25 Mar 2025US 12,258,377 B2Scancell Limited
- Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis25 Feb 2025US 12,235,268 B2Benaroya Research Institute at Virginia Mason
- Mass spectrometry-based method for simultaneous qualitative and quantitative protein citrullination analysis of complex biological samples8 Oct 2024US 12,111,322 B2Wisconsin Alumni Research Foundation
- Biomolecule analysis by fluorescence intermittence signal recognition9 Jul 2026US 2026/0194529 A1UniversitäT ZüRich
- Phenylglyoxal-Based Alkyne (PGA) Chemical Tag for Protein Citrullination Analysis4 Dec 2025US 2025/0369981 A1Wisconsin Alumni Research Foundation
- Use of anti-citrullinated peptide antibody as biomarker for diagnosis and prognosis of aortic valve stenosis6 Nov 2025US 2025/0341528 A1The Asan Foundation
- Systems and methods for rheumatoid arthritis biomarker detection21 Aug 2025US 2025/0264466 A1DiabetOmics, LLC
- Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis22 May 2025US 2025/0164481 A1
Most cited
By later US patents
- Anti-tumour response to modified self-epitopes4US 10,233,220 B2Scancell Limited · 2019
- Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration2US 10,365,288 B2The Johns Hopkins University · 2019
- Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration2US 9,709,573 B2The Johns Hopkins University · 2017
- Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis1US 10,132,806 B2Augurex Life Sciences Corp. · 2018
- Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease1US 10,309,974 B2Cedars-Sinai Medical Center · 2019